Generally

All information about migraines, headaches, cluster headaches, chronic pain, pain clinic, migraine clinic, headache center

September 1 ,

September 5th is Headache Day

September 5th, 2012 is International Headache Day. On this occasion, we remind you of the most important rule for the medication-based treatment of headaches, the "10-20 rule". The overuse of painkillers for headaches [...]

August 23, 2012 August 23, 2012

G-BA: Verapamil for cluster headache

According to a recent decision by the Federal Joint Committee (G-BA), the calcium antagonist verapamil will in future be prescribable under statutory health insurance for the indication of cluster headache, even beyond its current approved indication. The Federal Joint Committee has [...]

July 5, 2012 July 5, 2012

Forum meeting of www.headbook.me, July 27-29, 2012

This year's forum meeting of www.headbook.me will take place on the last weekend of July 2012. Details can be found in the organizing group. Since many participants will be arriving on Friday, July 27, 2012, the meeting will begin – as always [...]

June 1, 2012 June 1, 2012

Action Day Against Pain, June 5, 2012

As part of the Action Day Against Pain, the German Pain Society (Deutsche Schmerzgesellschaft e.V.) is calling on clinics and pain therapy facilities on Tuesday, June 5, 2012, to raise public awareness of the crucial health issue of pain therapy. The [...]

May 3, 2012 May 3, 2012

For BKK-insured persons: Coordinated care for migraine and headache

Patients insured with BKK health insurance who suffer from migraines, headaches, and neuralgia can now receive even better medical care. The BKK Contractual Working Group NORD (BKK-VAG NORD) and the Kiel Pain Clinic have established the contractual framework for coordinated care for [...]

April 19 ,

In Memoriam Professor Dr. med. Dieter Soyka

Professor Dr. Dieter Soyka passed away in Kiel on April 14, 2012, at the age of 82. His life, marked by his unparalleled work as a neurologist, pain therapist, scientist, teacher, and author, was a blessing [...]

April 11 ,

New: Headaches. 3rd edition 2012

The standard work on headaches, migraines, and neuralgia. Headaches are the number one health problem. Over 250 different primary diagnoses are currently distinguished. This work comprehensively and uniquely on the German market describes the classification and diagnosis of all [...]

April 11 ,

Migraine 2012: New publication

By Prof. Dr. Hartmut Göbel, new publication April 2012, Springer-Verlag, Heidelberg. A throbbing, pounding, and knocking in the head. Every movement intensifies the agony. Migraine is one of the most significant widespread diseases worldwide. It causes severe disability, significant limitations in [...]

February 22, 2012 February 22, 2012

Successfully combating migraines – The new 6th edition

In the new, fully updated 6th edition (2012), Prof. Dr. Hartmut Göbel informs you about the forms and causes of modern diagnostic possibilities, behavioral strategies for prevention, modern medications, and alternative treatment methods. Compiled for you: all current therapies, addresses of [...]

January 3, 2012 January 3, 2012

Non-aspirin painkillers may increase the risk of miscarriage

Acetylsalicylic acid should not be taken during the first and second trimesters of pregnancy unless medically necessary. This is due to the increased risk of miscarriage and birth defects. New studies now show that even [...]

December 4, 2011 December 4, 2011

GenoFutura Award 2011

(Gießen, November 24, 2011) At the 2nd Congress “Municipal Cooperation – Regional Future Management” on November 24, 2011 in Gießen, the integrated headache treatment concept, including the regional and nationwide headache treatment network of the Kiel Pain Clinic, was awarded the GenoFutura Award 2011. [...]

November 25, 2011 November 25, 2011

Paroxysmal hemicrania and SUNCT syndrome

Paroxysmal hemicrania manifests as headache attacks with the same pain characteristics and accompanying symptoms as cluster headaches. However, the attacks are shorter in duration, occur much more frequently, predominantly affect women, and respond reliably to [...]

September 28, 2011 September 28, 2011

Chronic migraine: Diagnosis and origin

When the International Headache Society published the first edition of the International Classification of Headache Disorders (ICHD-I) in 1988, chronic migraine was not among the 165 listed diagnoses. Migraine [...]

September 28, 2011 September 28, 2011

Botulinum toxin for chronic migraine approved by the BfArM

The drug Botox® (botulinum toxin type A) was approved on September 23, 2011, for the relief of symptoms of chronic migraine in adults who have not responded adequately to prophylactic migraine treatments or [...]

September 20, 2011 September 20, 2011

The 10-20 rule in migraine and headache therapy

An increase and intensification of headaches due to overuse of painkillers or triptans must always be suspected when acute medication is required on more than ten days per month, regardless of the dose [...]

August 21, 2011 August 21, 2011

Cluster headache: Severe pain attacks occur in clusters over time

[media id=41] Medicine today distinguishes over 250 different types of headaches. Approximately 90 percent of patients suffer from migraines and tension headaches. But there are also rare forms of headache. These include the so-called [...]

July 29, 2011 July 29, 2011

Symposium with the CSG eV: Cluster Headache Competence Center

Five years of specialized competence center at the Kiel Pain Clinic in cooperation with the Federal Association of Self-Help Groups for Cluster Headache Sufferers and their Relatives. The Center for Rare Headache Disorders with Cluster Headache Competence Center at the Kiel Pain Clinic was founded in 2006 by [...]

July 29, 2011 July 29, 2011

Development of the CGRP antagonist Telcagepant will not be continued

Merck halts clinical development program for CGRP antagonist telcagepant. A new therapeutic mechanism for migraine treatment was developed for clinical application with the CGRP antagonists MK-0974 and MK-3207. These are two drugs currently undergoing clinical research programs [...]